Company Monitoring Page for Orexigen

latest headlines for company on cafepharma

Arena Approaches 50% Institutional Ownership
Seeking Alpha
Thu, 08/15/13 - 02:53 pm
Tags:
Arena Pharmaceuticals, Vivus, Orexigen, Belviq, Contrave, Qsymia
Orexigen Investigated By Class Action Firm
Seeking Alpha
Tue, 08/13/13 - 10:51 am
Tags:
Orexigen, Class Action Lawsuit
Orexigen Therapeutics Announces European Filing Strategy and Reports Business and Financial Results for the Second Quarter Ended June 30, 2013
Yahoo
Wed, 08/7/13 - 09:45 am
Tags:
earnings, Orexigen
Vivus Weight-Loss Pill Scripts Are Surging
TheStreet.com
Tue, 07/30/13 - 01:30 pm
Tags:
Vivus, obesity, Qsymia, Arena Pharmaceuticals, Orexigen
The Best- And Worst-Performing Biotech Stocks July 19 To July 26
Forbes
Mon, 07/29/13 - 12:27 pm
Tags:
TearLab, Array Biopharma, Furiex Pharmaceuticals, InterMune, Prosensa, Boston Scientific, Orexigen, Momenta, Ironwood, INSYS Therapeutics, Sequenom, OncoMed, Abraxis, Sarepta, Epizyme, Tesaro, Synta Pharmaceuticals, Bluebird Bio, Exelixis, Lexicon Pharmaceuticals, Intercept Pharma, GTx
The Obesity Drug Battle
Seeking Alpha
Wed, 07/10/13 - 01:56 pm
Tags:
obesity, Belviq, Arena Pharmaceuticals, Contrave, Orexigen, Vivus, Qsymia, Roche, Xenical, GSK
The Hidden Way to Invest in Obesity
Motley Fool
Sun, 06/30/13 - 10:40 am
Tags:
Orexigen, obesity, weight loss, Contrave
Is The Anti-Obesity Space Going To Get Crowded?
Seeking Alpha
Mon, 06/24/13 - 10:52 am
Tags:
obesity, Arena Pharmaceuticals, Orexigen, Vivus, beloranib, Zagfen, Contrave, Belviq, Qsymia
Obesity Sector Gets New Shoes
Seeking Alpha
Thu, 06/20/13 - 07:48 am
Tags:
obesity, Arena Pharmaceuticals, Vivus, Orexigen, Contrave, Belviq, Qsymia
2 Biotech Approval Outcomes That Might Affect You
Motley Fool
Wed, 06/19/13 - 11:08 am
Tags:
drug approvals, Afrezza, MannKind, Contrave, Orexigen
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
TheStreet.com
Fri, 06/7/13 - 08:07 am
Tags:
Zerenex, Xoma, Vical, Takeda, sovaprevir, Soluble Ferric Pyrophosphate, Rockwell Medical, Orexigen, MM-398, Merrimack Pharmaceuticals, MannKind, Keryx, GTx, GSK, gevokizumab, enobosarm, Coronado Biosciences, Contrave, CNDO-201, clinical trials, ChemoCentryx, CCX140, Biodel, BIOD-123, Amigal, Amicus Therapeutics, Alnylam, ALN-TTR02, Allovectin, Afrezza, Achillion, ACH-3102
Arena And Vivus Investors: Do Not Fear A Market Correction
Seeking Alpha
Tue, 06/4/13 - 12:38 pm
Tags:
Vivus, Arena Pharmaceuticals, Orexigen, obesity
Arena: Marketing An Anti-Obesity Drug
Seeking Alpha
Thu, 05/30/13 - 09:03 am
Tags:
Arena Pharmaceuticals, obesity, Vivus, Orexigen, Belviq, Qsymia, Eisai
Is Novo A Threat To Arena, Vivus, And Orexigen?
Seeking Alpha
Thu, 05/30/13 - 09:02 am
Tags:
obesity, Novo Nordisk, Victoza, Arena Pharmaceuticals, Vivus, Orexigen
3 Pipeline Obesity Treatments You Should Watch
Motley Fool
Thu, 05/23/13 - 12:03 pm
Tags:
obesity, Vivus, Orexigen, Contrave, Belviq, tesofensine, Neurosearch, Qsymia, Arena Pharmaceuticals
Will Obesity Drugs Gain Soon?
Motley Fool
Wed, 05/15/13 - 09:50 am
Tags:
obesity, Novo Nordisk, Arena Pharmaceuticals, Vivus, Orexigen, Belviq, Contrave, Qsymia, Victoza
Is Orexigen Therapeutics Burning Too Much Cash?
Motley Fool
Wed, 05/8/13 - 09:13 am
Tags:
Orexigen
Vivus And Anti-Obesity Sector Benefit From New Insurance Deal
Seeking Alpha
Wed, 05/1/13 - 09:54 am
Tags:
Vivus, obesity, Orexigen, Arena Pharmaceuticals, Qsymia, Medco
Exciting Catalysts Approaching for This Bet
Motley Fool
Sun, 04/28/13 - 12:07 pm
Tags:
obesity, weight loss, Arena Pharmaceuticals, Vivus, Orexigen, Belviq, Qsymia
Arena Faces A Convergence Of DEA And European Decisions
Seeking Alpha
Wed, 04/24/13 - 10:25 am
Tags:
Arena Pharmaceuticals, Europe, DEA, Eisai, Vivus, Orexigen

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.